Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Nguyen

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Journal of Medical Economics|March 31, 2025
All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023Jingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
Journal of Medical Economics|June 27, 2025
Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in FranceJingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
The Pediatric Infectious Disease Journal|December 19, 2023
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort StudyJingyan Yang, Kathleen M Andersen, Kiran K Rai, et al.
American Journal of Therapeutics|May 1, 2024
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature ReviewAshley S Cha-Silva, Meghan B Gavaghan, Tobias Bergroth, et al.
BMJ Open|December 28, 2023
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort studyJingyan Yang, Kathleen Michelle Andersen, Kiran K Rai, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Plos One|February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platformHannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
Scientific Reports|October 21, 2025
Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged 0-17 years in ItalyRossana Scutari, Valeria Fox, Jennifer L Nguyen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Journal of Medical Economics|March 31, 2025
All-cause healthcare resource utilization and costs among community-managed adults with long-COVID in France, 2020-2023Jingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
Journal of Medical Economics|June 27, 2025
Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in FranceJingyan Yang, Cheikh Tamberou, Elise Arnee, et al.
The Pediatric Infectious Disease Journal|December 19, 2023
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort StudyJingyan Yang, Kathleen M Andersen, Kiran K Rai, et al.
American Journal of Therapeutics|May 1, 2024
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature ReviewAshley S Cha-Silva, Meghan B Gavaghan, Tobias Bergroth, et al.
BMJ Open|December 28, 2023
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort studyJingyan Yang, Kathleen Michelle Andersen, Kiran K Rai, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Plos One|February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platformHannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
Scientific Reports|October 21, 2025
Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged 0-17 years in ItalyRossana Scutari, Valeria Fox, Jennifer L Nguyen, et al.
Pageof 7